In the past year, the pharmaceutical industry has navigated a variety of global disruptions and technological advancements. How can pharmaceutical companies set themselves up for success during challenging times? Ian Bilodeau, managing director, Ardena US, sees AI as a way for companies to bridge fragmented databases and, potentially, outpace their competitors.
“I think it’s not just about using the technology to do the analysis on the compound, but how do you embed this technology, the AI, in your day-to-day decision making and accelerating the process in which you develop your product? I think that’s a big game changer,” Bilodeau…
